

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.90813742 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.90813742 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.50865761 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.50865761 |
| 5 | interkinetic nuclear migration (GO:0022027) | 5.18216978 |
| 6 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.93980199 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.71195062 |
| 8 | negative regulation of complement activation (GO:0045916) | 4.21073031 |
| 9 | bile acid biosynthetic process (GO:0006699) | 4.10990241 |
| 10 | urea cycle (GO:0000050) | 4.05685275 |
| 11 | urea metabolic process (GO:0019627) | 4.05685275 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 4.00953835 |
| 13 | negative regulation of protein activation cascade (GO:2000258) | 4.00828139 |
| 14 | lysine catabolic process (GO:0006554) | 4.00198399 |
| 15 | lysine metabolic process (GO:0006553) | 4.00198399 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95269014 |
| 17 | establishment of protein localization to Golgi (GO:0072600) | 3.94616518 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 3.84791581 |
| 19 | phospholipid translocation (GO:0045332) | 3.84279695 |
| 20 | lipid translocation (GO:0034204) | 3.84279695 |
| 21 | glyoxylate metabolic process (GO:0046487) | 3.81079278 |
| 22 | cysteine metabolic process (GO:0006534) | 3.79505315 |
| 23 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.77892669 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 3.73010898 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 3.69534660 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 3.69534660 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.66227492 |
| 28 | tyrosine metabolic process (GO:0006570) | 3.66121985 |
| 29 | tryptophan catabolic process (GO:0006569) | 3.64402141 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 3.64402141 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 3.64402141 |
| 32 | valine metabolic process (GO:0006573) | 3.63819043 |
| 33 | protein K11-linked deubiquitination (GO:0035871) | 3.61532579 |
| 34 | tryptophan metabolic process (GO:0006568) | 3.60248448 |
| 35 | short-chain fatty acid metabolic process (GO:0046459) | 3.59849977 |
| 36 | response to nitrosative stress (GO:0051409) | 3.55749767 |
| 37 | cellular glucuronidation (GO:0052695) | 3.53961613 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 3.52200577 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51008551 |
| 40 | fatty acid beta-oxidation (GO:0006635) | 3.49976699 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 3.45864047 |
| 42 | bile acid metabolic process (GO:0008206) | 3.44048221 |
| 43 | cellular response to ethanol (GO:0071361) | 3.43675427 |
| 44 | complement activation, alternative pathway (GO:0006957) | 3.40219056 |
| 45 | fatty acid catabolic process (GO:0009062) | 3.40067405 |
| 46 | biotin metabolic process (GO:0006768) | 3.35974913 |
| 47 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.35532626 |
| 48 | protein targeting to Golgi (GO:0000042) | 3.35488882 |
| 49 | fatty acid oxidation (GO:0019395) | 3.35088866 |
| 50 | neural tube formation (GO:0001841) | 3.34799477 |
| 51 | uronic acid metabolic process (GO:0006063) | 3.32230589 |
| 52 | glucuronate metabolic process (GO:0019585) | 3.32230589 |
| 53 | monocarboxylic acid catabolic process (GO:0072329) | 3.31196032 |
| 54 | coenzyme catabolic process (GO:0009109) | 3.29515066 |
| 55 | positive regulation of muscle hypertrophy (GO:0014742) | 3.28878976 |
| 56 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.28878976 |
| 57 | succinate metabolic process (GO:0006105) | 3.27114820 |
| 58 | lipid oxidation (GO:0034440) | 3.27038373 |
| 59 | kynurenine metabolic process (GO:0070189) | 3.26788074 |
| 60 | 2-oxoglutarate metabolic process (GO:0006103) | 3.26666073 |
| 61 | labyrinthine layer development (GO:0060711) | 3.25448641 |
| 62 | nucleus localization (GO:0051647) | 3.25373237 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 3.24707896 |
| 64 | homocysteine metabolic process (GO:0050667) | 3.23381004 |
| 65 | protein localization to Golgi apparatus (GO:0034067) | 3.22723131 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 3.22614212 |
| 67 | acylglycerol homeostasis (GO:0055090) | 3.19771091 |
| 68 | triglyceride homeostasis (GO:0070328) | 3.19771091 |
| 69 | early endosome to late endosome transport (GO:0045022) | 3.18427903 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 3.17604861 |
| 71 | reverse cholesterol transport (GO:0043691) | 3.14719108 |
| 72 | acyl-CoA biosynthetic process (GO:0071616) | 3.13969953 |
| 73 | thioester biosynthetic process (GO:0035384) | 3.13969953 |
| 74 | Golgi to endosome transport (GO:0006895) | 3.13833177 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 3.13272597 |
| 76 | carnitine transmembrane transport (GO:1902603) | 3.12647463 |
| 77 | regulation of establishment of cell polarity (GO:2000114) | 3.11915554 |
| 78 | phospholipid efflux (GO:0033700) | 3.11787310 |
| 79 | positive regulation of developmental pigmentation (GO:0048087) | 3.11687093 |
| 80 | amino-acid betaine transport (GO:0015838) | 3.11546603 |
| 81 | carnitine transport (GO:0015879) | 3.11546603 |
| 82 | ether lipid metabolic process (GO:0046485) | 3.10561268 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 3.09889892 |
| 84 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.09112990 |
| 85 | thrombin receptor signaling pathway (GO:0070493) | 3.09060287 |
| 86 | acetyl-CoA metabolic process (GO:0006084) | 3.08895276 |
| 87 | branched-chain amino acid metabolic process (GO:0009081) | 3.08524619 |
| 88 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.08509287 |
| 89 | regulation of pigment cell differentiation (GO:0050932) | 3.08067809 |
| 90 | regulation of protein activation cascade (GO:2000257) | 3.07910061 |
| 91 | pericardium development (GO:0060039) | 3.07353666 |
| 92 | neutral lipid catabolic process (GO:0046461) | 3.06716725 |
| 93 | acylglycerol catabolic process (GO:0046464) | 3.06716725 |
| 94 | ketone body metabolic process (GO:1902224) | 3.05070753 |
| 95 | prenylation (GO:0097354) | 3.04342028 |
| 96 | protein prenylation (GO:0018342) | 3.04342028 |
| 97 | organic acid catabolic process (GO:0016054) | 3.04277622 |
| 98 | carboxylic acid catabolic process (GO:0046395) | 3.04277622 |
| 99 | triglyceride catabolic process (GO:0019433) | 3.03795174 |
| 100 | xenobiotic catabolic process (GO:0042178) | 3.01307146 |
| 101 | toxin transport (GO:1901998) | 3.01076337 |
| 102 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00521317 |
| 103 | negative regulation of neurotransmitter transport (GO:0051589) | 2.99484754 |
| 104 | positive regulation of fatty acid oxidation (GO:0046321) | 2.98477581 |
| 105 | macroautophagy (GO:0016236) | 2.97685816 |
| 106 | oxaloacetate metabolic process (GO:0006107) | 2.97156826 |
| 107 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.96825948 |
| 108 | protein carboxylation (GO:0018214) | 2.96825948 |
| 109 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.96567560 |
| 110 | phospholipid homeostasis (GO:0055091) | 2.96127257 |
| 111 | aspartate family amino acid catabolic process (GO:0009068) | 2.94857329 |
| 112 | myelin assembly (GO:0032288) | 2.94654690 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 2.94018361 |
| 114 | regulation of fibrinolysis (GO:0051917) | 2.93664130 |
| 115 | negative regulation of humoral immune response (GO:0002921) | 2.93370904 |
| 116 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.92298230 |
| 117 | drug metabolic process (GO:0017144) | 2.92022016 |
| 118 | regulation of complement activation (GO:0030449) | 2.90007128 |
| 119 | regulation of protein polyubiquitination (GO:1902914) | 2.89821647 |
| 120 | benzene-containing compound metabolic process (GO:0042537) | 2.87354384 |
| 121 | regulation of cholesterol esterification (GO:0010872) | 2.87052595 |
| 122 | regulation of protein glycosylation (GO:0060049) | 2.86481947 |
| 123 | drug catabolic process (GO:0042737) | 2.86365991 |
| 124 | serine family amino acid catabolic process (GO:0009071) | 2.84437194 |
| 125 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83566014 |
| 126 | glutamate metabolic process (GO:0006536) | 2.83431456 |
| 127 | COPII vesicle coating (GO:0048208) | 2.83322958 |
| 128 | protein targeting to vacuole (GO:0006623) | 2.83026649 |
| 129 | protein targeting to lysosome (GO:0006622) | 2.83026649 |
| 130 | establishment of protein localization to vacuole (GO:0072666) | 2.83026649 |
| 131 | fibroblast migration (GO:0010761) | 2.82998070 |
| 132 | cellular modified amino acid catabolic process (GO:0042219) | 2.82747985 |
| 133 | aldehyde catabolic process (GO:0046185) | 2.82691919 |
| 134 | microtubule anchoring (GO:0034453) | 2.82566680 |
| 135 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.82142104 |
| 136 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.81846401 |
| 137 | indolalkylamine metabolic process (GO:0006586) | 2.81246040 |
| 138 | protein-lipid complex remodeling (GO:0034368) | 2.80669164 |
| 139 | macromolecular complex remodeling (GO:0034367) | 2.80669164 |
| 140 | plasma lipoprotein particle remodeling (GO:0034369) | 2.80669164 |
| 141 | ethanol oxidation (GO:0006069) | 2.79824939 |
| 142 | amino-acid betaine metabolic process (GO:0006577) | 2.79777112 |
| 143 | plasma lipoprotein particle clearance (GO:0034381) | 2.78021909 |
| 144 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.76904580 |
| 145 | NADH metabolic process (GO:0006734) | 2.75341466 |
| 146 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.74150373 |
| 147 | flavonoid metabolic process (GO:0009812) | 2.73075789 |
| 148 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.72886322 |
| 149 | acyl-CoA metabolic process (GO:0006637) | 2.72002256 |
| 150 | thioester metabolic process (GO:0035383) | 2.72002256 |
| 151 | positive regulation of granulocyte differentiation (GO:0030854) | 2.71860367 |
| 152 | regulation of lipoprotein metabolic process (GO:0050746) | 2.71104403 |
| 153 | nuclear pore complex assembly (GO:0051292) | 2.70647142 |
| 154 | protein K48-linked deubiquitination (GO:0071108) | 2.70280853 |
| 155 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.67011739 |
| 156 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.66807237 |
| 157 | response to pheromone (GO:0019236) | 2.66158761 |
| 158 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.64337234 |
| 159 | organelle membrane fusion (GO:0090174) | 2.63872645 |
| 160 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.63469914 |
| 161 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.61569868 |
| 162 | definitive hemopoiesis (GO:0060216) | 2.60278964 |
| 163 | neurotransmitter catabolic process (GO:0042135) | 2.58677731 |
| 164 | nerve growth factor signaling pathway (GO:0038180) | 2.58572163 |
| 165 | fatty acid transmembrane transport (GO:1902001) | 2.56179511 |
| 166 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.53826721 |
| 167 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.51624737 |
| 168 | positive regulation of glycolytic process (GO:0045821) | 2.50668222 |
| 169 | iron ion import (GO:0097286) | 2.49642791 |
| 170 | inositol metabolic process (GO:0006020) | 2.49377447 |
| 171 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.48348676 |
| 172 | negative regulation of DNA repair (GO:0045738) | 2.47449630 |
| 173 | quaternary ammonium group transport (GO:0015697) | 2.46872674 |
| 174 | regulation of muscle hypertrophy (GO:0014743) | 2.43218979 |
| 175 | nuclear pore organization (GO:0006999) | 2.43120717 |
| 176 | histone mRNA catabolic process (GO:0071044) | 2.43075584 |
| 177 | intracellular lipid transport (GO:0032365) | 2.41622136 |
| 178 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.40975262 |
| 179 | regulation of sulfur metabolic process (GO:0042762) | 2.40774809 |
| 180 | histone H3-K9 methylation (GO:0051567) | 2.39249756 |
| 181 | auditory receptor cell differentiation (GO:0042491) | 2.37516650 |
| 182 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.36096851 |
| 183 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.35679979 |
| 184 | relaxation of cardiac muscle (GO:0055119) | 2.34156955 |
| 185 | replicative senescence (GO:0090399) | 2.34121271 |
| 186 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.33316074 |
| 187 | carnitine shuttle (GO:0006853) | 2.32618391 |
| 188 | regulation of sarcomere organization (GO:0060297) | 2.31996107 |
| 189 | cardiolipin metabolic process (GO:0032048) | 2.29741835 |
| 190 | histone H3-K4 trimethylation (GO:0080182) | 2.29565633 |
| 191 | regulation of cofactor metabolic process (GO:0051193) | 2.29367494 |
| 192 | regulation of coenzyme metabolic process (GO:0051196) | 2.29367494 |
| 193 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.28868521 |
| 194 | protein K63-linked deubiquitination (GO:0070536) | 2.26494808 |
| 195 | negative regulation of digestive system process (GO:0060457) | 2.25750840 |
| 196 | endosome to melanosome transport (GO:0035646) | 2.21846734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.66235042 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.95478873 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.74840186 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.03712019 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97276324 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.45166821 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.19038498 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.68727209 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.63895823 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.60724063 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.57817484 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.48825098 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.43165819 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.41808321 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.33808295 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.31174137 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.21054381 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00852473 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95446818 |
| 20 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.92294964 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85131339 |
| 22 | EWS_26573619_Chip-Seq_HEK293_Human | 1.79502606 |
| 23 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.78770562 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78714803 |
| 25 | TP53_16413492_ChIP-PET_HCT116_Human | 1.78086490 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.75914258 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72162730 |
| 28 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.68340160 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66752494 |
| 30 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.61496969 |
| 31 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.61396545 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.57565001 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.57565001 |
| 34 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56883105 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56710118 |
| 36 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.56636456 |
| 37 | TCF4_23295773_ChIP-Seq_U87_Human | 1.56060876 |
| 38 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.52467957 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51976455 |
| 40 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.51962023 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.48450466 |
| 42 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.47604221 |
| 43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46140961 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45316508 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44859842 |
| 46 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.44553124 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41095833 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40103717 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39771645 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38604334 |
| 51 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.38226913 |
| 52 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.37391410 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36803703 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34769333 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.34665246 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31825412 |
| 57 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31632277 |
| 58 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.31238774 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30942453 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30940066 |
| 61 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30181862 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28933010 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28130636 |
| 64 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25820788 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25319069 |
| 66 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23344542 |
| 67 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.23333460 |
| 68 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.20983654 |
| 69 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.19767255 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19732242 |
| 71 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18883211 |
| 72 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.17889541 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17491313 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17428329 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17372629 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17101478 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16920445 |
| 78 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16436022 |
| 79 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.15277515 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14945292 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14909936 |
| 82 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.13786342 |
| 83 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.13708795 |
| 84 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13378053 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12768791 |
| 86 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12540697 |
| 87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11608592 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11189026 |
| 89 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10959816 |
| 90 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09672140 |
| 91 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08868353 |
| 92 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08823133 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08716373 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08489488 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08474892 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08254939 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08006111 |
| 98 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07449214 |
| 99 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.06818260 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05829332 |
| 101 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05495262 |
| 102 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.05138082 |
| 103 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04777175 |
| 104 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04669105 |
| 105 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04559737 |
| 106 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04540419 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04472112 |
| 108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04472112 |
| 109 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.03876886 |
| 110 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03876886 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03867306 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02336657 |
| 113 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99977211 |
| 114 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99846205 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99381281 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98561450 |
| 117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97662159 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97113901 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94900714 |
| 120 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92751481 |
| 121 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.91862259 |
| 122 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.91773520 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.89984976 |
| 124 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89192105 |
| 125 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89115549 |
| 126 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87536853 |
| 127 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.87492400 |
| 128 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.87492400 |
| 129 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86652149 |
| 130 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83612964 |
| 131 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83284160 |
| 132 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83203376 |
| 133 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.82943246 |
| 134 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.82837331 |
| 135 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81813552 |
| 136 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81813552 |
| 137 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81074710 |
| 138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79326144 |
| 139 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.77962022 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77952873 |
| 141 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76759602 |
| 142 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76271333 |
| 143 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.76108640 |
| 144 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75925863 |
| 145 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75845076 |
| 146 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75772629 |
| 147 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.75214638 |
| 148 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75040558 |
| 149 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.74486425 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.74350924 |
| 151 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74329934 |
| 152 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74148059 |
| 153 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73846674 |
| 154 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72951967 |
| 155 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.72171221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 8.00808367 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.98338303 |
| 3 | MP0005365_abnormal_bile_salt | 5.10616079 |
| 4 | MP0005360_urolithiasis | 5.03328962 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.65680374 |
| 6 | MP0008057_abnormal_DNA_replication | 4.19639076 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.75891715 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.46890106 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 3.34666499 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.06269896 |
| 11 | MP0003195_calcinosis | 2.93723720 |
| 12 | MP0003252_abnormal_bile_duct | 2.68496915 |
| 13 | MP0005670_abnormal_white_adipose | 2.54046274 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.50657112 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.46809581 |
| 16 | MP0005083_abnormal_biliary_tract | 2.39200725 |
| 17 | MP0005187_abnormal_penis_morphology | 2.38152094 |
| 18 | MP0000383_abnormal_hair_follicle | 2.36207503 |
| 19 | MP0006054_spinal_hemorrhage | 2.35031532 |
| 20 | MP0003787_abnormal_imprinting | 2.27385295 |
| 21 | MP0005332_abnormal_amino_acid | 2.23272162 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.17872349 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.15091205 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 2.09350013 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.08760437 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.99360423 |
| 27 | MP0004484_altered_response_of | 1.97085387 |
| 28 | MP0002009_preneoplasia | 1.96207091 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.95835394 |
| 30 | MP0004130_abnormal_muscle_cell | 1.91081081 |
| 31 | MP0009840_abnormal_foam_cell | 1.88191963 |
| 32 | MP0010678_abnormal_skin_adnexa | 1.87355655 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.86521028 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.81793091 |
| 35 | MP0004043_abnormal_pH_regulation | 1.73318392 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.71351701 |
| 37 | MP0000609_abnormal_liver_physiology | 1.70596915 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.64617026 |
| 39 | MP0003868_abnormal_feces_composition | 1.64226764 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.62135074 |
| 41 | MP0000371_diluted_coat_color | 1.60939862 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.60659839 |
| 43 | MP0003890_abnormal_embryonic-extraembry | 1.59853389 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.59117885 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58098088 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.57825300 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 1.54234425 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.53656826 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.51937755 |
| 50 | MP0004084_abnormal_cardiac_muscle | 1.45061028 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.42966856 |
| 52 | MP0002102_abnormal_ear_morphology | 1.38815585 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.36600559 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.34068487 |
| 55 | MP0005535_abnormal_body_temperature | 1.31518678 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.31187661 |
| 57 | MP0001764_abnormal_homeostasis | 1.29464694 |
| 58 | MP0006276_abnormal_autonomic_nervous | 1.27863068 |
| 59 | MP0002971_abnormal_brown_adipose | 1.26441915 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.25293165 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.24205386 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.21121873 |
| 63 | MP0000647_abnormal_sebaceous_gland | 1.19542503 |
| 64 | MP0003943_abnormal_hepatobiliary_system | 1.15494270 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.15277903 |
| 66 | MP0008775_abnormal_heart_ventricle | 1.14342275 |
| 67 | MP0005266_abnormal_metabolism | 1.14332186 |
| 68 | MP0002095_abnormal_skin_pigmentation | 1.13854103 |
| 69 | MP0005334_abnormal_fat_pad | 1.12276084 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.12190206 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.10734589 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 1.09221786 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.07865694 |
| 74 | MP0001984_abnormal_olfaction | 1.05897870 |
| 75 | MP0005375_adipose_tissue_phenotype | 1.05203727 |
| 76 | MP0004147_increased_porphyrin_level | 1.03175270 |
| 77 | MP0003121_genomic_imprinting | 1.02639319 |
| 78 | MP0003329_amyloid_beta_deposits | 1.00680267 |
| 79 | MP0002928_abnormal_bile_duct | 1.00550907 |
| 80 | MP0001944_abnormal_pancreas_morphology | 1.00096233 |
| 81 | MP0003828_pulmonary_edema | 0.99500413 |
| 82 | MP0005448_abnormal_energy_balance | 0.99123755 |
| 83 | MP0001501_abnormal_sleep_pattern | 0.98928868 |
| 84 | MP0001529_abnormal_vocalization | 0.97878467 |
| 85 | MP0004233_abnormal_muscle_weight | 0.96824040 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.96164583 |
| 87 | MP0001756_abnormal_urination | 0.94789546 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.94350758 |
| 89 | MP0002822_catalepsy | 0.94311171 |
| 90 | MP0009384_cardiac_valve_regurgitation | 0.93999845 |
| 91 | MP0004134_abnormal_chest_morphology | 0.93469959 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.93374912 |
| 93 | MP0000604_amyloidosis | 0.92931273 |
| 94 | MP0001661_extended_life_span | 0.92740517 |
| 95 | MP0003690_abnormal_glial_cell | 0.92492251 |
| 96 | MP0003953_abnormal_hormone_level | 0.91455536 |
| 97 | MP0002168_other_aberrant_phenotype | 0.91232779 |
| 98 | MP0001879_abnormal_lymphatic_vessel | 0.90350947 |
| 99 | MP0003045_fibrosis | 0.90086322 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.89903687 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 0.89589766 |
| 102 | MP0005253_abnormal_eye_physiology | 0.88406918 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 0.87276580 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.87159822 |
| 105 | MP0004270_analgesia | 0.85780289 |
| 106 | MP0005379_endocrine/exocrine_gland_phen | 0.81725695 |
| 107 | MP0004883_abnormal_blood_vessel | 0.80928266 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.80762547 |
| 109 | MP0003724_increased_susceptibility_to | 0.80357362 |
| 110 | MP0005503_abnormal_tendon_morphology | 0.80131171 |
| 111 | MP0008007_abnormal_cellular_replicative | 0.79876992 |
| 112 | MP0005386_behavior/neurological_phenoty | 0.79060440 |
| 113 | MP0004924_abnormal_behavior | 0.79060440 |
| 114 | MP0003122_maternal_imprinting | 0.79027741 |
| 115 | MP0000598_abnormal_liver_morphology | 0.78849493 |
| 116 | MP0002254_reproductive_system_inflammat | 0.77368306 |
| 117 | MP0004264_abnormal_extraembryonic_tissu | 0.77147885 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75610422 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.75264847 |
| 120 | MP0002736_abnormal_nociception_after | 0.74879500 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.74172151 |
| 122 | MP0003186_abnormal_redox_activity | 0.73132845 |
| 123 | MP0002970_abnormal_white_adipose | 0.73113274 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.72711420 |
| 125 | MP0003763_abnormal_thymus_physiology | 0.72599376 |
| 126 | MP0009115_abnormal_fat_cell | 0.72379126 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.72310277 |
| 128 | MP0003300_gastrointestinal_ulcer | 0.71899085 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.70942632 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.70866831 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.70378617 |
| 132 | MP0001324_abnormal_eye_pigmentation | 0.70132504 |
| 133 | MP0005620_abnormal_muscle_contractility | 0.68539543 |
| 134 | MP0001177_atelectasis | 0.68376054 |
| 135 | MP0008874_decreased_physiological_sensi | 0.68067169 |
| 136 | MP0003959_abnormal_lean_body | 0.67892202 |
| 137 | MP0004381_abnormal_hair_follicle | 0.67830614 |
| 138 | MP0002069_abnormal_eating/drinking_beha | 0.67423840 |
| 139 | MP0000427_abnormal_hair_cycle | 0.66977594 |
| 140 | MP0009697_abnormal_copulation | 0.66644303 |
| 141 | MP0002638_abnormal_pupillary_reflex | 0.65663800 |
| 142 | MP0003011_delayed_dark_adaptation | 0.65560053 |
| 143 | MP0002128_abnormal_blood_circulation | 0.64096546 |
| 144 | MP0010368_abnormal_lymphatic_system | 0.63919467 |
| 145 | MP0002090_abnormal_vision | 0.63586906 |
| 146 | MP0002166_altered_tumor_susceptibility | 0.63428760 |
| 147 | MP0002177_abnormal_outer_ear | 0.63055922 |
| 148 | MP0002108_abnormal_muscle_morphology | 0.63055217 |
| 149 | MP0001968_abnormal_touch/_nociception | 0.62942457 |
| 150 | MP0008004_abnormal_stomach_pH | 0.62677645 |
| 151 | MP0009765_abnormal_xenobiotic_induced | 0.62566447 |
| 152 | MP0005408_hypopigmentation | 0.62414421 |
| 153 | MP0005452_abnormal_adipose_tissue | 0.62413114 |
| 154 | MP0001915_intracranial_hemorrhage | 0.62284275 |
| 155 | MP0009046_muscle_twitch | 0.61434054 |
| 156 | MP0003937_abnormal_limbs/digits/tail_de | 0.61419464 |
| 157 | MP0008770_decreased_survivor_rate | 0.60012228 |
| 158 | MP0002067_abnormal_sensory_capabilities | 0.60009753 |
| 159 | MP0005376_homeostasis/metabolism_phenot | 0.58527102 |
| 160 | MP0001784_abnormal_fluid_regulation | 0.58281222 |
| 161 | MP0004036_abnormal_muscle_relaxation | 0.57882046 |
| 162 | MP0005164_abnormal_response_to | 0.57812281 |
| 163 | MP0006035_abnormal_mitochondrial_morpho | 0.57644665 |
| 164 | MP0005395_other_phenotype | 0.57495507 |
| 165 | MP0002272_abnormal_nervous_system | 0.57488853 |
| 166 | MP0003646_muscle_fatigue | 0.56529325 |
| 167 | MP0003633_abnormal_nervous_system | 0.55193728 |
| 168 | MP0000538_abnormal_urinary_bladder | 0.54628087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.68669444 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.66916645 |
| 3 | Xanthomatosis (HP:0000991) | 4.47982687 |
| 4 | Ketosis (HP:0001946) | 4.47318749 |
| 5 | Papillary thyroid carcinoma (HP:0002895) | 4.42983802 |
| 6 | Increased mean platelet volume (HP:0011877) | 4.41675611 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.28336428 |
| 8 | Ketoacidosis (HP:0001993) | 4.22965573 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.22206855 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.12677898 |
| 11 | Abnormal platelet volume (HP:0011876) | 3.92737937 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 3.81339292 |
| 13 | Hyperammonemia (HP:0001987) | 3.75299757 |
| 14 | Complement deficiency (HP:0004431) | 3.65189092 |
| 15 | Poikilocytosis (HP:0004447) | 3.64141128 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.63638668 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 3.57357417 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.54788236 |
| 19 | Hyperglycinemia (HP:0002154) | 3.53840615 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.51976763 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.51976763 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.51852465 |
| 23 | Hypoglycemic seizures (HP:0002173) | 3.49322896 |
| 24 | Generalized hypopigmentation of hair (HP:0011358) | 3.46001728 |
| 25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41250842 |
| 26 | Hyperglycinuria (HP:0003108) | 3.36323757 |
| 27 | Gingival bleeding (HP:0000225) | 3.32413539 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.27165334 |
| 29 | Epidermoid cyst (HP:0200040) | 3.26145006 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.25851971 |
| 31 | Oligomenorrhea (HP:0000876) | 3.24742446 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.22348907 |
| 33 | Absent speech (HP:0001344) | 3.21592014 |
| 34 | Gaze-evoked nystagmus (HP:0000640) | 3.20307156 |
| 35 | Protruding tongue (HP:0010808) | 3.14324234 |
| 36 | Prolonged bleeding time (HP:0003010) | 3.09879399 |
| 37 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.04652229 |
| 38 | Thyroid carcinoma (HP:0002890) | 3.03349852 |
| 39 | Gout (HP:0001997) | 2.98280875 |
| 40 | Chronic hepatic failure (HP:0100626) | 2.96265850 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 2.95003829 |
| 42 | Hyperglycemia (HP:0003074) | 2.90336223 |
| 43 | Short chin (HP:0000331) | 2.88346777 |
| 44 | Drooling (HP:0002307) | 2.84595451 |
| 45 | Renal cortical cysts (HP:0000803) | 2.83784431 |
| 46 | Abnormality of the renal cortex (HP:0011035) | 2.83636932 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.83033063 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.82509266 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.82305279 |
| 50 | Myoglobinuria (HP:0002913) | 2.79911417 |
| 51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79818713 |
| 52 | Symptomatic seizures (HP:0011145) | 2.70798395 |
| 53 | Widely spaced teeth (HP:0000687) | 2.69783159 |
| 54 | Menorrhagia (HP:0000132) | 2.68102154 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.66831690 |
| 56 | Tubulointerstitial nephritis (HP:0001970) | 2.63372183 |
| 57 | Acanthocytosis (HP:0001927) | 2.63233423 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.61455405 |
| 59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.60892758 |
| 60 | Excessive salivation (HP:0003781) | 2.59699617 |
| 61 | Metabolic acidosis (HP:0001942) | 2.59496228 |
| 62 | Blue irides (HP:0000635) | 2.55055533 |
| 63 | Late onset (HP:0003584) | 2.52392191 |
| 64 | Volvulus (HP:0002580) | 2.52259275 |
| 65 | Abnormality of complement system (HP:0005339) | 2.51337288 |
| 66 | * Abnormality of serum amino acid levels (HP:0003112) | 2.51236605 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.51064633 |
| 68 | Medial flaring of the eyebrow (HP:0010747) | 2.50960013 |
| 69 | Truncal obesity (HP:0001956) | 2.50746200 |
| 70 | Central scotoma (HP:0000603) | 2.49216015 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.49168305 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49168305 |
| 73 | Cerebral edema (HP:0002181) | 2.48417330 |
| 74 | Disproportionate short-trunk short stature (HP:0003521) | 2.47565630 |
| 75 | Febrile seizures (HP:0002373) | 2.47282385 |
| 76 | Fat malabsorption (HP:0002630) | 2.43964751 |
| 77 | Broad-based gait (HP:0002136) | 2.43935762 |
| 78 | Hyperkalemia (HP:0002153) | 2.43872463 |
| 79 | Exercise-induced myalgia (HP:0003738) | 2.43784654 |
| 80 | Neoplasm of the small intestine (HP:0100833) | 2.43285011 |
| 81 | Biliary tract neoplasm (HP:0100574) | 2.42422353 |
| 82 | Skin nodule (HP:0200036) | 2.42029282 |
| 83 | Lethargy (HP:0001254) | 2.34122929 |
| 84 | Hyperbilirubinemia (HP:0002904) | 2.34012160 |
| 85 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.33276242 |
| 86 | Increased muscle lipid content (HP:0009058) | 2.32932730 |
| 87 | Acute myeloid leukemia (HP:0004808) | 2.27080502 |
| 88 | Hyperventilation (HP:0002883) | 2.20569773 |
| 89 | Glycosuria (HP:0003076) | 2.19991099 |
| 90 | Abnormality of urine glucose concentration (HP:0011016) | 2.19991099 |
| 91 | Pancreatic cysts (HP:0001737) | 2.19900099 |
| 92 | Abnormality of the wing of the ilium (HP:0011867) | 2.15449422 |
| 93 | Thyroiditis (HP:0100646) | 2.14493944 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.12812770 |
| 95 | Amyloidosis (HP:0011034) | 2.12736502 |
| 96 | Enlarged kidneys (HP:0000105) | 2.12178074 |
| 97 | Hepatocellular carcinoma (HP:0001402) | 2.11813691 |
| 98 | Long clavicles (HP:0000890) | 2.10691082 |
| 99 | Abnormality of nucleobase metabolism (HP:0010932) | 2.08819038 |
| 100 | Brushfield spots (HP:0001088) | 2.08796263 |
| 101 | Abnormality of the renal medulla (HP:0100957) | 2.07014808 |
| 102 | Irritability (HP:0000737) | 2.06792208 |
| 103 | Hypoplastic iliac wings (HP:0002866) | 2.06019957 |
| 104 | Abnormal biliary tract morphology (HP:0012440) | 2.05143990 |
| 105 | Metaphyseal dysplasia (HP:0100255) | 2.04433199 |
| 106 | Epistaxis (HP:0000421) | 2.04196836 |
| 107 | Mitral stenosis (HP:0001718) | 2.03874083 |
| 108 | Scotoma (HP:0000575) | 2.02637861 |
| 109 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.01883554 |
| 110 | Vomiting (HP:0002013) | 2.00456357 |
| 111 | Acute encephalopathy (HP:0006846) | 2.00377177 |
| 112 | Tubulointerstitial abnormality (HP:0001969) | 1.99664129 |
| 113 | Prominent nose (HP:0000448) | 1.98316455 |
| 114 | Increased purine levels (HP:0004368) | 1.97789693 |
| 115 | Hyperuricemia (HP:0002149) | 1.97789693 |
| 116 | Fair hair (HP:0002286) | 1.96135492 |
| 117 | Subaortic stenosis (HP:0001682) | 1.96062739 |
| 118 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.96062739 |
| 119 | Gonadotropin excess (HP:0000837) | 1.95502418 |
| 120 | Hepatic necrosis (HP:0002605) | 1.95285081 |
| 121 | Hypothermia (HP:0002045) | 1.94935395 |
| 122 | Abnormal gallbladder morphology (HP:0012437) | 1.94905154 |
| 123 | Pancreatic fibrosis (HP:0100732) | 1.94317446 |
| 124 | Torticollis (HP:0000473) | 1.93931911 |
| 125 | Joint hemorrhage (HP:0005261) | 1.93662706 |
| 126 | Exotropia (HP:0000577) | 1.93193892 |
| 127 | Vascular calcification (HP:0004934) | 1.90925459 |
| 128 | Pheochromocytoma (HP:0002666) | 1.90525052 |
| 129 | Abnormality of midbrain morphology (HP:0002418) | 1.90196615 |
| 130 | Molar tooth sign on MRI (HP:0002419) | 1.90196615 |
| 131 | Intestinal atresia (HP:0011100) | 1.89135604 |
| 132 | Cerebral palsy (HP:0100021) | 1.89001148 |
| 133 | Protuberant abdomen (HP:0001538) | 1.88672686 |
| 134 | Abnormality of the ischium (HP:0003174) | 1.88574456 |
| 135 | Cerebellar dysplasia (HP:0007033) | 1.88532127 |
| 136 | Portal hypertension (HP:0001409) | 1.87934453 |
| 137 | Craniofacial dystonia (HP:0012179) | 1.87531836 |
| 138 | Abnormality of the pubic bones (HP:0003172) | 1.87180367 |
| 139 | Thyroid-stimulating hormone excess (HP:0002925) | 1.87151197 |
| 140 | Growth hormone excess (HP:0000845) | 1.85955680 |
| 141 | Cone-rod dystrophy (HP:0000548) | 1.85850687 |
| 142 | Curly hair (HP:0002212) | 1.85798324 |
| 143 | Tachypnea (HP:0002789) | 1.85088263 |
| 144 | Barrel-shaped chest (HP:0001552) | 1.84657916 |
| 145 | Type II lissencephaly (HP:0007260) | 1.84053860 |
| 146 | Systemic lupus erythematosus (HP:0002725) | 1.83775056 |
| 147 | Albinism (HP:0001022) | 1.82706422 |
| 148 | Lipid accumulation in hepatocytes (HP:0006561) | 1.81912542 |
| 149 | Hypercholesterolemia (HP:0003124) | 1.81730325 |
| 150 | Methylmalonic aciduria (HP:0012120) | 1.81238941 |
| 151 | Insulin resistance (HP:0000855) | 1.80384349 |
| 152 | Clumsiness (HP:0002312) | 1.78925814 |
| 153 | Poor coordination (HP:0002370) | 1.78491581 |
| 154 | Vacuolated lymphocytes (HP:0001922) | 1.78417282 |
| 155 | Pancreatitis (HP:0001733) | 1.77826601 |
| 156 | Increased intramyocellular lipid droplets (HP:0012240) | 1.77798842 |
| 157 | Nephronophthisis (HP:0000090) | 1.77458650 |
| 158 | Spontaneous abortion (HP:0005268) | 1.75948466 |
| 159 | Macroorchidism (HP:0000053) | 1.74549241 |
| 160 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.73502356 |
| 161 | Calf muscle hypertrophy (HP:0008981) | 1.73464910 |
| 162 | Cardiovascular calcification (HP:0011915) | 1.73196184 |
| 163 | Limb hypertonia (HP:0002509) | 1.73002692 |
| 164 | Neuroendocrine neoplasm (HP:0100634) | 1.72375404 |
| 165 | EEG with generalized epileptiform discharges (HP:0011198) | 1.72348004 |
| 166 | Neoplasm of the rectum (HP:0100743) | 1.72209439 |
| 167 | Proximal tubulopathy (HP:0000114) | 1.72122005 |
| 168 | Opisthotonus (HP:0002179) | 1.71260286 |
| 169 | Hyperphosphaturia (HP:0003109) | 1.70758829 |
| 170 | Myocardial infarction (HP:0001658) | 1.70134370 |
| 171 | Hip dysplasia (HP:0001385) | 1.70051700 |
| 172 | Epileptiform EEG discharges (HP:0011182) | 1.69877882 |
| 173 | Hypoplastic labia majora (HP:0000059) | 1.68438169 |
| 174 | Thickened calvaria (HP:0002684) | 1.67822377 |
| 175 | Inability to walk (HP:0002540) | 1.65082329 |
| 176 | Genital tract atresia (HP:0001827) | 1.64146777 |
| 177 | Congenital primary aphakia (HP:0007707) | 1.61238909 |
| 178 | Chorioretinal atrophy (HP:0000533) | 1.60999090 |
| 179 | Cupped ear (HP:0000378) | 1.60871151 |
| 180 | Large for gestational age (HP:0001520) | 1.60811182 |
| 181 | True hermaphroditism (HP:0010459) | 1.59929981 |
| 182 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.59056493 |
| 183 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.59056493 |
| 184 | Genetic anticipation (HP:0003743) | 1.57826784 |
| 185 | Conjunctival telangiectasia (HP:0000524) | 1.57733118 |
| 186 | Neoplasm of the thyroid gland (HP:0100031) | 1.57323717 |
| 187 | Abnormality of potassium homeostasis (HP:0011042) | 1.55824635 |
| 188 | Abnormality of the nasal septum (HP:0000419) | 1.55435566 |
| 189 | Abnormality of the parathyroid morphology (HP:0011766) | 1.55351575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.28362123 |
| 2 | ACVR1B | 3.86333599 |
| 3 | INSRR | 3.86131213 |
| 4 | ERN1 | 3.20313927 |
| 5 | FRK | 3.11312267 |
| 6 | AKT3 | 2.65636913 |
| 7 | MAP2K4 | 2.56341620 |
| 8 | SIK1 | 2.51894936 |
| 9 | MAPK15 | 2.33617706 |
| 10 | LATS1 | 2.30266317 |
| 11 | STK38L | 2.26015802 |
| 12 | MAP3K12 | 2.20051716 |
| 13 | FLT3 | 2.16221933 |
| 14 | OBSCN | 2.06440230 |
| 15 | MAP3K13 | 2.03304161 |
| 16 | FGFR4 | 2.01553411 |
| 17 | TEC | 1.89238462 |
| 18 | MAP3K6 | 1.89021553 |
| 19 | MAP2K7 | 1.88395199 |
| 20 | NUAK1 | 1.76721103 |
| 21 | CAMK1D | 1.76269164 |
| 22 | CASK | 1.69935993 |
| 23 | ERBB3 | 1.64890212 |
| 24 | PKN2 | 1.62269791 |
| 25 | STK39 | 1.62159353 |
| 26 | PRKD3 | 1.61540333 |
| 27 | MAP3K4 | 1.59407182 |
| 28 | MAP4K2 | 1.58785494 |
| 29 | PHKG1 | 1.55378198 |
| 30 | PHKG2 | 1.55378198 |
| 31 | NEK9 | 1.54774792 |
| 32 | STK3 | 1.50103494 |
| 33 | TRPM7 | 1.47899817 |
| 34 | TAOK3 | 1.43073172 |
| 35 | PDK2 | 1.39011067 |
| 36 | TGFBR2 | 1.36091291 |
| 37 | EPHA4 | 1.33131961 |
| 38 | PIK3CG | 1.31907092 |
| 39 | CAMK1G | 1.29356207 |
| 40 | PINK1 | 1.28751545 |
| 41 | RET | 1.26998503 |
| 42 | TRIB3 | 1.25317799 |
| 43 | FER | 1.20270801 |
| 44 | TGFBR1 | 1.15788860 |
| 45 | MYLK | 1.14974569 |
| 46 | YES1 | 1.14137875 |
| 47 | TNIK | 1.13160823 |
| 48 | BRSK2 | 1.09497983 |
| 49 | NTRK3 | 1.08259539 |
| 50 | FGFR2 | 1.07196255 |
| 51 | MAP3K2 | 1.05188067 |
| 52 | WNK3 | 1.00506700 |
| 53 | BCR | 0.99906270 |
| 54 | ARAF | 0.93926129 |
| 55 | WNK1 | 0.93742032 |
| 56 | KSR1 | 0.93554844 |
| 57 | SGK2 | 0.93453337 |
| 58 | SGK494 | 0.90941935 |
| 59 | SGK223 | 0.90941935 |
| 60 | TAF1 | 0.90568150 |
| 61 | PRKCH | 0.89986468 |
| 62 | BTK | 0.89208678 |
| 63 | DAPK2 | 0.88618407 |
| 64 | TRIM28 | 0.86637399 |
| 65 | ADRBK2 | 0.85946316 |
| 66 | CSNK1G2 | 0.84951823 |
| 67 | CAMKK2 | 0.83935570 |
| 68 | SIK3 | 0.82017734 |
| 69 | JAK1 | 0.81867791 |
| 70 | PAK3 | 0.79676635 |
| 71 | EIF2AK3 | 0.79312724 |
| 72 | GRK5 | 0.77549141 |
| 73 | BMPR2 | 0.76078179 |
| 74 | SYK | 0.75334793 |
| 75 | MAP3K14 | 0.75225282 |
| 76 | GRK1 | 0.74997635 |
| 77 | PIK3CA | 0.74257814 |
| 78 | MAP2K1 | 0.73468514 |
| 79 | BRD4 | 0.73434093 |
| 80 | ITK | 0.73105207 |
| 81 | NTRK1 | 0.73076885 |
| 82 | STK24 | 0.72867142 |
| 83 | MINK1 | 0.72579921 |
| 84 | CAMK2G | 0.72540006 |
| 85 | MAP3K7 | 0.72151303 |
| 86 | CSNK1G3 | 0.71696991 |
| 87 | MUSK | 0.70472849 |
| 88 | FGFR3 | 0.69736800 |
| 89 | ADRBK1 | 0.69657943 |
| 90 | TYK2 | 0.67619180 |
| 91 | PRKAA2 | 0.67051523 |
| 92 | PBK | 0.66812347 |
| 93 | MAPKAPK5 | 0.66471108 |
| 94 | PTK2B | 0.65245957 |
| 95 | RAF1 | 0.64706029 |
| 96 | CSNK1G1 | 0.61626851 |
| 97 | PDK4 | 0.60271075 |
| 98 | PDK3 | 0.60271075 |
| 99 | MAPK11 | 0.60128836 |
| 100 | SGK1 | 0.60090875 |
| 101 | IRAK1 | 0.59372645 |
| 102 | EIF2AK1 | 0.58985265 |
| 103 | CSNK1A1L | 0.58626796 |
| 104 | HCK | 0.57603713 |
| 105 | ZAK | 0.56885432 |
| 106 | MELK | 0.55868435 |
| 107 | GRK7 | 0.54276737 |
| 108 | PRKAA1 | 0.53439276 |
| 109 | MST4 | 0.53402755 |
| 110 | MKNK2 | 0.52128282 |
| 111 | PDGFRB | 0.52077637 |
| 112 | JAK2 | 0.51561372 |
| 113 | MAP2K3 | 0.51094372 |
| 114 | IGF1R | 0.50150478 |
| 115 | MAPKAPK3 | 0.49501302 |
| 116 | CSF1R | 0.49300199 |
| 117 | KIT | 0.48565584 |
| 118 | LMTK2 | 0.48360143 |
| 119 | PDGFRA | 0.47870995 |
| 120 | FGFR1 | 0.47854225 |
| 121 | WNK4 | 0.46495842 |
| 122 | CSNK1D | 0.46251465 |
| 123 | OXSR1 | 0.46063169 |
| 124 | NEK6 | 0.45593689 |
| 125 | CDK6 | 0.45503548 |
| 126 | PRKCE | 0.44997026 |
| 127 | MAPK13 | 0.44804957 |
| 128 | IRAK3 | 0.43994392 |
| 129 | PDPK1 | 0.43877495 |
| 130 | PLK2 | 0.43714826 |
| 131 | SCYL2 | 0.42784338 |
| 132 | SGK3 | 0.42349962 |
| 133 | PDK1 | 0.40413552 |
| 134 | MAPK7 | 0.40210335 |
| 135 | PRKCZ | 0.40206325 |
| 136 | CAMK2A | 0.39847901 |
| 137 | PRKACG | 0.39517429 |
| 138 | PIM1 | 0.39325913 |
| 139 | MAPK12 | 0.37795465 |
| 140 | PRKCQ | 0.37521287 |
| 141 | ERBB2 | 0.37499211 |
| 142 | RPS6KA2 | 0.36966614 |
| 143 | DMPK | 0.35635849 |
| 144 | PRPF4B | 0.35481184 |
| 145 | MAP3K5 | 0.34407853 |
| 146 | BMPR1B | 0.34191002 |
| 147 | RPS6KB1 | 0.33748313 |
| 148 | MST1R | 0.32445800 |
| 149 | NLK | 0.32090888 |
| 150 | CDK5 | 0.31832578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.30949073 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.72283811 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70711073 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.65931021 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.60151152 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55243105 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.38039529 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.26803963 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26191373 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.21549458 |
| 11 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.16509269 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15606945 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 2.15037357 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14164278 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.14031303 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.11236729 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.00295194 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.97314074 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96350954 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89213272 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.88896189 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87666264 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.87636072 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.82989571 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.68586253 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.63121798 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62064860 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61505401 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56453530 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54697181 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52790982 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51859488 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51214592 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50897811 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.48650840 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.48278893 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43244546 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42998999 |
| 39 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.42156020 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40915099 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39290455 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36865678 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.29200098 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26754776 |
| 45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.26509599 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.26326856 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21497276 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.18217078 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15618064 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15547701 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14400997 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14041329 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.13100388 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11010938 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08071222 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07168242 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06293821 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.03931703 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99778016 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99205531 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98102732 |
| 62 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96891599 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.93381830 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.87775782 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.87676770 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87561281 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86792254 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85939840 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85202812 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83915717 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82803261 |
| 72 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82623959 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82324989 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82212864 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81848219 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.79884817 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78227196 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77716064 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77457127 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77000482 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75921051 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74097629 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73717907 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73308049 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72377027 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72084204 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71782816 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71593041 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71562029 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71349591 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.67346218 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.67135114 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66887823 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.66720440 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66201008 |
| 96 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66022019 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65750861 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61960367 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61606890 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61228873 |
| 101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60957954 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60355338 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59956646 |
| 104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59625704 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58681659 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57918403 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57875959 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56753893 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.56136061 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55942267 |
| 111 | Phototransduction_Homo sapiens_hsa04744 | 0.55394622 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55377419 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.54798359 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54405551 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54181793 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.53922567 |
| 117 | Alcoholism_Homo sapiens_hsa05034 | 0.53789769 |
| 118 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52250014 |
| 119 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50073694 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49827669 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49744899 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48914618 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47973501 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47582508 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45519400 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44306644 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43600385 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43494517 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42063668 |
| 130 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40158385 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39702697 |
| 132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39055438 |
| 133 | Prion diseases_Homo sapiens_hsa05020 | 0.37338198 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.36784715 |
| 135 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35965626 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35728679 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33364083 |
| 138 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29777549 |
| 139 | Renin secretion_Homo sapiens_hsa04924 | 0.29232506 |
| 140 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29231357 |
| 141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28848204 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28728172 |
| 143 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27898836 |
| 144 | GABAergic synapse_Homo sapiens_hsa04727 | 0.27335923 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26880679 |
| 146 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26866764 |
| 147 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26572090 |
| 148 | Lysine degradation_Homo sapiens_hsa00310 | 0.24411719 |
| 149 | Olfactory transduction_Homo sapiens_hsa04740 | 0.22600952 |
| 150 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.22443904 |
| 151 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.20816671 |
| 152 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19763045 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18859355 |
| 154 | Taste transduction_Homo sapiens_hsa04742 | 0.18287682 |
| 155 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.18011438 |
| 156 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.17804035 |

